Determining if an EAC is at risk and key actions to mitigate trial impact.
Shaena Kauffman
Advertisement
Executive Director, Operations EAC, WCG
Articles by Shaena Kauffman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
3
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
4
Redefining CRA Workflows Through Intelligent Automation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
